VRNA Verona Pharma plc ADRs

Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:VRP.

$20.72  +0.09 (0.44%)
As of 03/27/2023 11:51:06 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  04/27/2017
Outstanding shares:  51,818,198
Average volume:  513,805
Market cap:   $1,028,591,230
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BYWPZK5

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%